Anjana Pillai

Morning Lights. Sunday's sunrise in Chicago Harbor as the frozen lake starts to melt.

Really important morning session on how to build the transplant fellowship work force across all organs- timely initiative - early exposure, mentorship, impact of work, work life resources all very important area of focus @ast-licop.bsky.social #WTC2025

Thank you for highlighting our paper @atoosarabiee.bsky.social
If you want some light liver cancer learning ;)

🔥Nivolumab and Ipilimuma approved by EMA for advanced hepatocellular carcinoma 🔥
👇https://ec.europa.eu/health/documents/community-register/html/h1014.htm
👉great news for our patients > more options in 1st line
😅amazing: approval in 🇪🇺by EMA before 🇺🇸by FDA
@myESMO @EASLedu @ILCAnews #livertwitter

Spicy!

Adding lasix to the management of hepatorenal syndrome might be ok if you bump the MAP with pressors

@juancarlosqvelez.bsky.social

doi.org/10.1016/j.ek...
#nephsky #liversky

Join ACG for the next Virtual Grand Rounds—

ACG Clinical Guideline: Focal Liver Lesions
Reena J. Salgia, MD

Thursday, February 27 at Noon & 8pm ET
➡️ gi.org/ACGVGR

Every year I feel so fortunate to be part of this #LiverCancer community with these amazing friends who are true leaders sharing a common goal!! Amongst the beautiful chaos that is life, it’s important to find your passion and your people 💚. That’s a wrap @hcclive.bsky.social

Registration is now open! We're so excited to welcome you to the 2025 HCC-LIVE Conference. See you at the Welcome Reception at 6:30!

DEI isn't racist. The people who say it is often are. As someone who has worked in "DEI," broadly speaking, for almost 15 years, here's what right-wing propagandists get so, so wrong and why we actually need DEI.

Seems like a good time to re-share my essay which has a whole section titled, “What, even, is ‘DEI’?”

arghavan.substack.com/p/dei-isnt-r...

Kirema Garcia-Reyes is giving a Critical Assessment of EMERALD -1 at HCC Live! Make sure to attend this session for a review of data, treatment efficacy, and safety findings from the EMERALD-1 clinical study @kiremagarciamd

Join the Debate: Drs. Riad Salem and Mishal Mendiratta-Lala Face Off on Histosonics vs. SBRT! Don’t miss this compelling discussion and more at HCC Live.

Enjoy 40% off registration until January 31st!
👉 Register now: loom.ly/7h0SJyM

Dr. Tanios Bekaii- Saab is presenting at HCC Live! You wont want to miss this. Register now at loom.ly/7h0SJyM.

Course Director Spotlight: Join Anjana Pillai, MD at the HCC-LIVE Conference - Space is Limited - Register Now!
@anjanapillaimd.bsky.social

Read this

A review of reported adverse events for medications to treat alcohol use disorder

we must reduce alcohol use in people with liver disease

And to increase uptake of useful tools …

we need stop repeating that naltrexone is hepatotoxic

doi.org/10.1016/j.cg...

Hello #livertwitter friends- if you’re a liver cancer expert or want to be, please join us Feb 20-22 in Austin! We’d love to see you there! www.hcc-live.org @hcclive.bsky.social

🎊Happy Holidays from your #HCC-LIVE conference crew! We are excited to see our fellow #livercancer enthusiasts in Austin Feb 20-22. We’d love for you to join our growing community!! Also submit your abstracts by 12/27 loom.ly/UBi8KDc

Treating Patients, Not P Values To the dismay of many statisticians, clinicians are taught to convert continuous results into a binary value to facilitate decision-making. A person with a hemoglobin A1c level of 6.5% or higher ha...

Really good review for those of us who are not always digging into statistical methods #livertwitter

evidence.nejm.org/doi/full/10....

🎉Happy holidays my fellow liver lovers I’m sure many of you have seen this but thought I’d leave this right here 😉🎁

www.instagram.com/share/BAEBdk...

Locoregional Therapies for Hepatocellular Carcinoma This systematic review and meta-analysis compares findings from randomized clinical trials on the use of locoregional therapies as monotherapy or combination therapy in the treatment of nonmetastatic ...

Systematic review & meta-analysis of locoregional therapies for #HCC in @jama.com network open

✅Inclusion:
RCTs with PFS and OS as endpoints

✅Conclusions:
Resection > thermal ablation ~ RT ~ HAIC > embolization

#oncsky #radonc #radsky #liversky

ja.ma/3ONRpQ1